Immunologic risk stratification of pediatric heart transplant patients by combining HLA-EMMA and PIRCHE-II.

Ellison M, Mangiola M, Marrari M, Bentlejewski C, Sadowski J, Zern D, Kramer CSM, Heidt S, Niemann M, Xu Q, Dipchand AI, Mahle WT, Rossano JW, Canter CE, Singh TP, Zuckerman WA, Hsu DT, Feingold B, Webber SA, Zeevi A

Open source

DOI
10.3389/fimmu.2023.1110292
Published
2023
Container
Frontiers in immunology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2023.1110292,
  title = {Immunologic risk stratification of pediatric heart transplant patients by combining HLA-EMMA and PIRCHE-II.},
  author = {Ellison M and Mangiola M and Marrari M and Bentlejewski C and Sadowski J and Zern D and Kramer CSM and Heidt S and Niemann M and Xu Q and Dipchand AI and Mahle WT and Rossano JW and Canter CE and Singh TP and Zuckerman WA and Hsu DT and Feingold B and Webber SA and Zeevi A},
  year = {2023},
  journal = {Frontiers in immunology},
  doi = {10.3389/fimmu.2023.1110292},
  url = {https://doi.org/10.3389/fimmu.2023.1110292}
}

RIS

TY  - JOUR
TI  - Immunologic risk stratification of pediatric heart transplant patients by combining HLA-EMMA and PIRCHE-II.
AU  - Ellison M
AU  - Mangiola M
AU  - Marrari M
AU  - Bentlejewski C
AU  - Sadowski J
AU  - Zern D
AU  - Kramer CSM
AU  - Heidt S
AU  - Niemann M
AU  - Xu Q
AU  - Dipchand AI
AU  - Mahle WT
AU  - Rossano JW
AU  - Canter CE
AU  - Singh TP
AU  - Zuckerman WA
AU  - Hsu DT
AU  - Feingold B
AU  - Webber SA
AU  - Zeevi A
PY  - 2023
JO  - Frontiers in immunology
DO  - 10.3389/fimmu.2023.1110292
UR  - https://doi.org/10.3389/fimmu.2023.1110292
ER  - 

APA

M, E., M, M., M, M., C, B., J, S., D, Z., CSM, K., S, H., M, N., Q, X., AI, D., WT, M., JW, R., CE, C., TP, S., WA, Z., DT, H., B, F., SA, W., & A, Z. (2023). Immunologic risk stratification of pediatric heart transplant patients by combining HLA-EMMA and PIRCHE-II.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2023.1110292

Source records